Estrone recalls
The FDA has published 3 recalls involving Estrone since 2017. The latest was reported on 24 Apr 2019. Most were for manufacturing (cgmp) deviations. Anderson Compounding Pharmacy has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 24 Apr 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why estrone is recalled
Companies
By year
All estrone recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estrone 5mg/mL Oil Injection Vial recalled | Anderson Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Estrone recalled by American Pharmaceutical | American Pharmaceutical Ingredients | Manufacturing (CGMP) Deviations | 6 states |
| Drug | CLASS II | Estrone, USP Bulk, in a) 100 mgs recalled by Medisca | Medisca | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Estrone?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.